Evidence map›Paper›PMID 19132807›Full record

ArticleDrug safety2009

An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain.

Consuelo Pedrós, Antoni Vallano, Gloria Cereza, Gemma Mendoza-Aran, Antònia Agustí, Cristina Aguilera, Immaculada Danés, Xavier Vidal, Josep M Arnau

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Drug safety, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02134587 (Implementation of a Hospital Pharmacovigilance Service and Comparison of Algorithms for Adverse Drug Reaction Causality Assessment), which is not on this map. Cited by 33 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 4 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02134587 nacompletednot on this mapstarted 2012, after this paper: background citation

Implementation of a Hospital Pharmacovigilance Service and Comparison of Algorithms for Adverse Drug Reaction Causality Assessment

TypeinterventionalSponsorUniversidade Estadual Paulista Júlio de Mesquita FilhoRan2012 to 2014Enrolled203ConditionsAdverse Drug ReactionArmsMultifaceted educational intervention
3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 4 syntheses or guidelines pooled it, 83 citations in OpenAlex.

  1. Improving adverse drug event reporting by healthcare professionals.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. A global view of undergraduate education in pharmacovigilance.European journal of clinical pharmacology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Consuelo PedrósFundació Institut Català de Farmacologia, Barcelona, Spain. cpedros@csub.scs.es
Antoni Vallano
Gloria Cereza
Gemma Mendoza-Aran
Antònia Agustí
Cristina Aguilera
Immaculada Danés
Xavier Vidal
Josep M Arnau
Universitat Autònoma de Barcelona · ESSociedad Española de Farmacología Clínica · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSpontaneous reporting of adverse drug reactions (ADRs) in hospitals is scarce and several obstacles to such reporting have been identified previously.

objectiveTo assess the effectiveness of a multifaceted intervention based on healthcare management agreements for improving spontaneous reporting of ADRs by physicians in a hospital setting.

methodsIn 2003, the spontaneous reporting of ADRs was included as one of the objectives of hospital physicians at the Vall d'Hebron Hospital, Barcelona, Spain, within the context of management agreements between clinical services and hospital managers. A continuous intervention related to these management agreements, including periodic educational meetings and economic incentives, was then initiated. We carried out an ecological time series analysis and assessed the change in the total number of spontaneous reports of ADRs, and the number of serious ADRs, unexpected ADRs, and ADRs associated with new drugs between a period previous to the intervention (from 1998 to 2002) and the period during the intervention (from 2003 to 2005). A time series analysis with ARIMA (Auto-Regressive Integrated Moving Average) models was performed.

resultsThe median number of reported ADRs per year increased from 40 (range 23-55) in the first period to 224 (range 98-248) in the second period. In the first period, the monthly number of reported ADRs was stable (3.47 per month; 95% CI 1.90, 5.03), but in the second period the number increased progressively (increase of 0.74 per month; 95% CI 0.62, 0.86). In the second period, the proportion of reported serious ADRs increased nearly 2-fold (63.1% vs 32.5% in the first period). The absolute number of previously unknown or poorly known ADRs increased 4-fold in the second period (54 vs 13 in the first period). There was also an increase in the absolute number of suspected pharmacological exposures to new drugs (97 vs 28) and in the number of different new drugs suspected of causing ADRs (50 vs 19).

conclusionA continuous intervention based on healthcare management agreements with economic incentives and educational activities is associated with a quantitative and qualitative improvement of spontaneous reporting of ADRs by hospital physicians.

Indexed as

Education, Medical, ContinuingAdverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsHospitalsHumansPhysiciansPractice Patterns, Physicians'Quality Assurance, Health CareReimbursement, IncentiveSpainTime Factors

Identifiers

PMID19132807
OpenAlexW28455800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.